Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP961649priorityCriticalpatent/ECSP961649A/en
Publication of ECSP961649ApublicationCriticalpatent/ECSP961649A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención proporciona contra la obesidad proteínas, que cuando se administra a un paciente regular tejido graso. En consecuencia, dichos agentes permiten a los pacientes a superar su desventaja obesidad y vivir una vida normal con mucho menor riesgo de diabetes tipo II, enfermedades cardiovasculares y el cáncer.The present invention provides anti-obesity proteins, which when administered to a patient regulate fatty tissue. Consequently, such agents enable patients to overcome their obesity disadvantage and live normal lives with much less risk of type II diabetes, cardiovascular disease and cancer.
ECSP9616491996-03-251996-03-25
ANTI-OBESITY PROTEINS (CASE X 10180M)
ECSP961649A
(en)
USE OF AN EFFECTIVE AMOUNT OF AT LEAST ONE PEPTIDE IN A COSMETIC COMPOSITION OR FOR THE PREPARATION OF A MEDICATION INTENDED TO PARATRATE INFLAMMATION, AND A COSMETIC TREATMENT PROCEDURE THROUGH A COSMETIC COMPOSITION CONTAINING SUCH PEPTIDE.